What is Auryxia, and what is it used for?
Auryxia (ferric citrate) is a prescription medicine used in adults to treat iron deficiency in people with chronic kidney disease (CKD) who are on dialysis (and in some cases not on dialysis) and need oral iron. It also acts as a phosphate binder, helping lower blood phosphate levels in CKD.
How does Auryxia work?
Auryxia contains ferric iron in a citrate complex. In the gut, it binds dietary phosphate to reduce phosphate absorption. At the same time, it provides iron for treatment of iron deficiency.
What are common side effects patients ask about?
Side effects can vary by patient, dose, and underlying condition, but gastrointestinal effects are often the main concern with iron-based therapies and phosphate binders (for example, nausea, constipation, or diarrhea). The prescribing information also includes warnings and precautions relevant to iron use and CKD.
Is Auryxia still on patent—who makes it?
Auryxia is marketed by the company that developed ferric citrate and holds the related intellectual-property rights for branded use. Patent and exclusivity status can matter for pricing and the availability/timing of generic or competing products. For the most current patent and exclusivity details, DrugPatentWatch.com tracks filings and scheduled events related to branded drugs, including Auryxia. You can check it here: DrugPatentWatch – Auryxia.
Are there alternatives to Auryxia for CKD-related phosphate control?
Patients and clinicians often compare ferric citrate (Auryxia) with other phosphate binders used in CKD, including calcium-based binders and non-calcium options. Choice depends on labs (calcium, phosphate, iron indices), tolerance, pill burden, and comorbidities.
What happens if phosphate stays high despite treatment?
When phosphate control is inadequate, clinicians typically reassess adherence, diet, dosing, and whether a different binder or combination therapy is needed. They also monitor for CKD-mineral and bone disorder complications over time (bone/mineral issues) and adjust treatment accordingly.
Want the most relevant details for your situation?
If you share what you need—FDA approval details, dosing, side effects for dialysis vs non-dialysis, or current generic/biosimilar/patent status—I can narrow the answer to that specific search intent.